Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy
Caroline B Madsen,
Hans H Wandall
,
Anders Elm Pedersen
Glycomics Program
8
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Immunotherapy
100%
Specific Antibodies
100%
MUC1 Glycopeptide
100%
Mucin 1 (MUC1)
66%
Glycopeptide Epitope
66%
Breast Cancer Cell Lines
33%
GalNAc
33%
Cancer-specific
33%
Monoclonal Antibody
33%
Mucin Glycans
33%
Cross-reactivity
33%
Immunodominant
33%
Mucin
33%
Peptide Backbone
33%
Immunology and Microbiology
MUC1
100%
Antibody
100%
Cancer Immunotherapy
100%
Glycopeptide
100%
Mucin
40%
Epitope
40%
Breast Cancer Cell Line
20%
Peptides
20%
Vertebral Column
20%
Glycan
20%
Monoclonal Antibody
20%
Cross-Reactivity
20%
Antibody-Dependent Cell-Mediated Cytotoxicity
20%